Literature DB >> 17090703

Hydroxyamide analogs of propofol exhibit state-dependent block of sodium channels in hippocampal neurons: implications for anticonvulsant activity.

Paulianda J Jones1, Yuesheng Wang, Misty D Smith, Nicholas J Hargus, Hilary S Eidam, H Steve White, Jaideep Kapur, Milton L Brown, Manoj K Patel.   

Abstract

Although propofol is most commonly known for its general anesthetic properties, at subanesthetic doses, propofol has been effectively used to suppress seizures during refractory status epilepticus, a mechanism, in part, attributed to the inhibition of neuronal sodium channels. In this study, we have designed and synthesized two novel analogs of propofol, HS245 [2-(3-ethyl-4-hydroxy-5-isopropyl-phenyl)-3,3,3-trifluoro-2-hydroxy-propionamide] and HS357 [2-hydroxy-8-(4-hydroxy-3,5-diisopropyl-phenyl)-2-trifluoromethyl-octanoic acid amide], and determined their effects on sodium currents recorded from cultured hippocampal neurons. HS357 had greater affinity for the inactivated state of the sodium channel than propofol and HS245 (0.22 versus 0.74 and 1.2 microM, respectively) and exhibited the greatest ratio of affinity for the resting over the inactivated state. HS357 also demonstrated greater use-dependent block and delayed recovery from inactivation in comparison with propofol and HS245. Under current-clamp conditions, action potentials from hippocampal CA1 neurons in slices were evoked by current injection, or following perfusion with a zero Mg(2+)/7 mM K(+) artificial cerebrospinal fluid solution. Propofol and HS357 reduced the number of current-induced action potentials; however, HS357 caused a greater reduction in the number of spontaneous action potentials. Consistent with these electrophysiology studies, propofol and HS357 protected mice against acute seizures in the 6-Hz (22-mA) partial psychomotor model. Efficacious doses of propofol were associated with an impairment of motor coordination as assessed in the rotorod toxicity assay. In contrast, HS357 demonstrated a 2-fold greater protective index than propofol. Thus, propofol analogs represent an important structural class from which not only effective, but also safer, anti-convulsants may be developed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090703     DOI: 10.1124/jpet.106.111542

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies.

Authors:  Yevgenij Yanovsky; Stephan Schubring; Wiebke Fleischer; Günter Gisselmann; Xin-Ran Zhu; Hermann Lübbert; Hanns Hatt; Uwe Rudolph; Helmut L Haas; Olga A Sergeeva
Journal:  Pflugers Arch       Date:  2011-07-07       Impact factor: 3.657

2.  Modulation of sodium channel inactivation gating by a novel lactam: implications for seizure suppression in chronic limbic epilepsy.

Authors:  Paulianda J Jones; Ellen C Merrick; Timothy W Batts; Nicholas J Hargus; Yuesheng Wang; James P Stables; Edward H Bertram; Milton L Brown; Manoj K Patel
Journal:  J Pharmacol Exp Ther       Date:  2008-10-24       Impact factor: 4.030

3.  CACHD1 is an α2δ-Like Protein That Modulates CaV3 Voltage-Gated Calcium Channel Activity.

Authors:  Graeme S Cottrell; Camille H Soubrane; James A Hounshell; Hong Lin; Venetia Owenson; Michael Rigby; Peter J Cox; Bryan S Barker; Matteo Ottolini; Selvi Ince; Claudia C Bauer; Edward Perez-Reyes; Manoj K Patel; Edward B Stevens; Gary J Stephens
Journal:  J Neurosci       Date:  2018-09-04       Impact factor: 6.167

4.  Propofol enhances both tonic and phasic inhibitory currents in second-order neurons of the solitary tract nucleus (NTS).

Authors:  Stuart J McDougall; Timothy W Bailey; David Mendelowitz; Michael C Andresen
Journal:  Neuropharmacology       Date:  2007-11-07       Impact factor: 5.250

5.  Kinetic Resolution of Racemic 2-Hydroxyamides Using a Diphenylacetyl Component as an Acyl Source and a Chiral Acyl-Transfer Catalyst.

Authors:  Takatsugu Murata; Tatsuya Kawanishi; Akihiro Sekiguchi; Ryo Ishikawa; Keisuke Ono; Kenya Nakata; Isamu Shiina
Journal:  Molecules       Date:  2018-08-10       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.